Skip to main content

BAFFR/TNFRSF13C Antibody Blocking Peptide

Novus Biologicals, part of Bio-Techne | Catalog # NBP1-77234PEP

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP1-77234PEP

Key Product Details

Source

Synthetic

Conjugate

Unconjugated

Applications

Antibody Competition

Product Specifications

Description

A blocking peptide containing 15 amino acids near the carboxy terminus of human BAFF Receptor.

Source: Synthetic

(Accession #: AAK91826)

Purity

N/A

Application Notes

This peptide is useful as a blocking peptide for NBP1-77234. For further blocking peptide related protocol, click here.

Protein / Peptide Type

Antibody Blocking Peptide

Formulation, Preparation and Storage

NBP1-77234PEP
Formulation PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
Preservative 0.02% Sodium Azide
Concentration 0.2 mg/ml
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Store at -20C. Avoid freeze-thaw cycles.

Background: BAFFR/TNFRSF13C

B cell-activating factor receptor (BAFF R) is a type III transmembrane protein belonging to the TNF receptor superfamily (TNFRSF13C). It is one of three TNFRSF members that binds to, and is activated by, BAFF. BAFF R binds only BAFF and no other TNFSF ligands. It is the critical receptor for BAFF during Blymphopoiesis.

Long Name

B cell Activating Factor Receptor

Alternate Names

BAFF R, BR3, CD268, TNFRSF13C

Gene Symbol

TNFRSF13C

Additional BAFFR/TNFRSF13C Products

Product Documents for BAFFR/TNFRSF13C Antibody Blocking Peptide

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for BAFFR/TNFRSF13C Antibody Blocking Peptide

This product is for research use only and is not approved for use in humans or in clinical diagnosis. This product is guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...